Nosocomial Acinetobacter Genomic Species 13 TU Endocarditis Following an Endoscopic Procedure

Antimicrobial susceptibility profile of Acinetobacter species isolated from blood cultures in two Japanese university hospitals

“…Unexpectedly, the incidence of A. pittii was high (42/123; 34.1%), exceeding that of A. baumannii (22/123; 17.9%). A recent study reported that bacteremia caused by A. baumannii and non‐ A. baumannii species has different clinical outcomes according to the species involved . Our findings emphasize the importance of accurate epidemiological investigation of non‐ A. baumannii species.…”

Incidence of Acinetobacter Species Other than A. baumannii among Clinical Isolates of Acinetobacter : Evidence for Emerging Species

“…baumannii isolates were from blood and were associated with bacteremia or septicemia. Of note is that some isolates (of A. johnsonii, genomic species 13, and A. beijerinckii) were implicated in endocarditis; this has been described for other Acinetobacter species (7,18,28) but FIG. 1.…”

Antibiotic prophylaxis for GI endoscopy

“…Despite an estimated 14.2 million colonoscopies, 2.8 million flexible sigmoidoscopies, and perhaps as many upper endoscopies performed in the United States each year, 3 only approximately 25 cases of IE have been reported with temporal association to an endoscopic procedure. [4][5][6] There are no data demonstrating a causal association between endoscopic procedures and IE or that antibiotic prophylaxis prior to endoscopic procedures protects against IE. Finally, much of the existing data reflects estimated risk associated with conventional endoscopic techniques.…”

“…Antibiotics that cover biliary flora such as enteric gram-negative organisms and enterococci should be used and continued after the procedure if biliary drainage is incomplete. (4 44B) 5. We recommend against antibiotic prophylaxis before diagnostic EUS or EUS-FNA of solid lesions of the GI tract.…”